Neonatal Abstinence Syndrome (NAS) is a growing public health concern affecting newborns whose mothers used drugs during pregnancy. The effects of NAS can range from mild to severe and can include irritability, poor feeding, and difficulty sleeping. The impact of NAS is far-reaching, affecting not only the newborn, but also the family, healthcare providers, and the community. In this article, we will explore the impact of NAS from a parent's perspective, including the physical, emotional, and financial challenges faced by families raising a newborn with NAS.
One of the primary physical challenges faced by families raising a newborn with NAS is the difficulty of providing adequate care. The newborn often requires more attention and care than a typical newborn due to the symptoms of NAS, which can include difficulty sleeping, frequent crying, and poor feeding. This can be especially challenging for parents who are already caring for other children or who have limited access to resources. Another physical challenge is the potential long-term effects of NAS. While some babies with NAS may experience no long-term effects, others may experience physical, cognitive, or behavioral issues that can persist into childhood. These issues can range from mild to severe and can include developmental delays, learning disabilities, and behavioral problems.
In addition to the physical challenges, families raising a newborn with NAS can also face emotional challenges. Parents may feel overwhelmed and anxious about the care of their newborn and the potential long-term effects of NAS. They may also feel guilty or ashamed about the circumstances of the baby's birth, even if they were not aware of the mother's drug use during pregnancy. The emotional challenges can extend beyond the parents to other family members, including siblings of the newborn. Siblings may feel neglected or jealous of the extra attention the newborn is receiving and may struggle to understand why the baby is behaving differently than other babies.
The financial challenges associated with raising a newborn with NAS can be significant. The cost of medical care for a newborn with NAS can be high, as the baby may require additional tests, medications, and treatments to manage the symptoms of NAS. In addition, families may need to take time off work to care for the newborn, resulting in lost wages. The financial burden can also extend beyond the immediate family. The cost of medical care for a newborn with NAS can be a strain on the healthcare system, as well as the community as a whole.
Raising a newborn with Neonatal Abstinence Syndrome can be a difficult and challenging experience for families. The physical, emotional, and financial challenges faced by parents can be overwhelming and can have a lasting impact. It is important for healthcare providers, family members, and the community to be aware of the impact of NAS and to provide support to families raising a newborn with NAS.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation